Total Payments
$11,677
2024 Payments
$2,121
Companies
20
Transactions
315
Medicare Patients
819
Medicare Billing
$88,237
Payment Breakdown by Category
Food & Beverage$9,777 (83.7%)
Consulting$1,900 (16.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,777 | 314 | 83.7% |
| Consulting Fee | $1,900 | 1 | 16.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $5,328 | 102 | $0 (2024) |
| Amgen Inc. | $2,170 | 48 | $0 (2024) |
| Amarin Pharma Inc. | $870.72 | 47 | $0 (2022) |
| Novo Nordisk Inc | $759.98 | 18 | $0 (2024) |
| Lilly USA, LLC | $665.58 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $550.47 | 19 | $0 (2024) |
| ABBVIE INC. | $519.07 | 25 | $0 (2024) |
| Axsome Therapeutics, Inc. | $262.50 | 2 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $114.50 | 5 | $0 (2023) |
| Allergan Inc. | $76.16 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,121 | 54 | Amgen Inc. ($759.17) |
| 2023 | $1,376 | 41 | Gilead Sciences, Inc. ($461.78) |
| 2022 | $1,172 | 28 | Novo Nordisk Inc ($452.91) |
| 2021 | $996.91 | 40 | Gilead Sciences, Inc. ($413.43) |
| 2020 | $448.19 | 21 | Gilead Sciences, Inc. ($203.61) |
| 2019 | $1,468 | 48 | Gilead Sciences, Inc. ($665.03) |
| 2018 | $3,166 | 49 | Gilead Sciences, Inc. ($2,567) |
| 2017 | $928.75 | 34 | Gilead Sciences Inc ($425.68) |
All Payment Transactions
315 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Bone Health | ||||||
| 11/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: HBV | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $118.73 | General |
| Category: Bone Health | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.87 | General |
| 09/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $8.17 | General |
| 08/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.31 | General |
| 08/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.50 | General |
| 07/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.07 | General |
| 07/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $134.99 | General |
| Category: Cardiology | ||||||
| 07/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Diabetes | ||||||
| 06/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Inflammation | ||||||
| 06/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Inflammation | ||||||
| 06/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 92 | 308 | $26,993 | $14,067 |
| 2022 | 8 | 194 | 326 | $44,440 | $23,511 |
| 2021 | 10 | 297 | 449 | $51,614 | $30,501 |
| 2020 | 9 | 236 | 298 | $36,224 | $20,158 |
Total Patients
819
Total Services
1,381
Medicare Billing
$88,237
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 96 | $19,843 | $10,060 | 50.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 30 | $4,386 | $1,933 | 44.1% |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | Office | 2023 | 21 | 162 | $2,430 | $1,905 | 78.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 20 | $334.00 | $168.00 | 50.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 161 | $33,112 | $17,602 | 53.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 36 | $5,311 | $2,852 | 53.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 14 | 14 | $1,725 | $959.56 | 55.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 14 | 17 | $1,515 | $858.60 | 56.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $800.00 | $567.36 | 70.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 23 | $920.00 | $314.86 | 34.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 17 | 19 | $665.00 | $238.10 | 35.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 31 | 40 | $391.50 | $118.59 | 30.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 184 | $35,132 | $21,393 | 60.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 35 | $4,704 | $2,924 | 62.2% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 38 | 39 | $3,120 | $1,757 | 56.3% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 32 | 32 | $2,560 | $1,121 | 43.8% |
| 0064A | Fee covid-19 vac 7 res | Office | 2021 | 24 | 24 | $1,940 | $1,101 | 56.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 15 | 15 | $1,148 | $978.90 | 85.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 19 | 19 | $924.99 | $388.39 | 42.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 26 | 28 | $957.05 | $363.50 | 38.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 24 | $866.32 | $327.36 | 37.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 37 | 49 | $262.75 | $147.00 | 55.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 48 | 83 | $16,067 | $8,637 | 53.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 41 | $5,515 | $2,960 | 53.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 23 | 28 | $4,999 | $2,865 | 57.3% |
About Dr. Celia Liang, DO
Dr. Celia Liang, DO is a Family Medicine healthcare provider based in Rego Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1396994018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Celia Liang, DO has received a total of $11,677 in payments from pharmaceutical and medical device companies, with $2,121 received in 2024. These payments were reported across 315 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($9,777).
As a Medicare-enrolled provider, Liang has provided services to 819 Medicare beneficiaries, totaling 1,381 services with total Medicare billing of $88,237. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Rego Park, NY
- Active Since 09/18/2008
- Last Updated 01/27/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1396994018
Products in Payments
- Vemlidy (Drug) $2,910
- Vascepa (Drug) $870.72
- Repatha (Biological) $687.24
- JARDIANCE (Drug) $560.11
- EVENITY (Biological) $529.89
- MOUNJARO (Drug) $429.36
- Otezla (Drug) $401.46
- Prolia (Biological) $390.25
- Rybelsus (Drug) $338.42
- Ozempic (Drug) $276.05
- Auvelity (Drug) $262.50
- QULIPTA (Drug) $259.50
- UBRELVY (Drug) $194.27
- Aimovig (Biological) $153.71
- FORTEO (Drug) $140.56
- Kerendia (Drug) $114.50
- LINZESS (Drug) $60.95
- XIFAXAN (Drug) $58.87
- COMIRNATY (Biological) $50.71
- CREON (Drug) $46.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Rego Park
Yanina Etlis, D.o, D.O
Family Medicine — Payments: $10,671
Family Medicine $10,671
Dr. Yanina Rubinshteyn, M.d, M.D
Family Medicine — Payments: $7,577
Family Medicine $7,577
Dr. Faye Rabinovich, Do, DO
Family Medicine — Payments: $2,822
Family Medicine $2,822
Izolda Mikhaylov, Do, DO
Family Medicine — Payments: $974.03
Family Medicine $974.03
Irina Kimyagarova, Do, DO
Family Medicine — Payments: $708.07
Family Medicine $708.07
Dr. Arvind Manik, D.o, D.O
Family Medicine — Payments: $287.62
Family Medicine $287.62